Alkalinization by Urologists & Nephrologists

PHASE4CompletedINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

February 1, 2017

Primary Completion Date

February 21, 2020

Study Completion Date

February 21, 2020

Conditions
Metabolic AcidosisNephrolithiasisExtracellular AlterationBlood PressureBody Weight
Interventions
DRUG

Alkali

Oral intake of alkali therapy whatever the formulation (alkali-based water, powder or pharmaceutics)

Trial Locations (18)

13005

La Conception University Hospital, AP-HM, Marseille

29600

La Cavale Blanche Hospital, Brest

35400

Aub Sante, St-Malo

38300

Centre Hospitalier Pierre Oudot - Bourgoin-Jallieu, Bourgoin

72016

E.C.H.O. (Expansion des Centres d'Hémodialyse de l'Ouest), Le Mans

75014

AURA Paris Plaisance, Paris

75908

European Georges Pompidou Hospital, Paris

83000

HIA Sainte-Anne, Toulon

Unknown

CHMS Chambery, Chambéry

University Hospital of Grenoble, Grenoble

Calydial, Irigny

Institut Phocéen de Néphrologie, Clinique Bouchard, Marseille

Uninversity Hospital of Nantes, Nantes

Tenon Hospital, AP-HP, Paris

Maison Blanche Hospital, Reims

Rennes Hospital, Rennes

Clinic area, Strasbourg

Clinique Sainte Anne, Strasbourg

All Listed Sponsors
lead

Jean-Philippe Bertocchio

OTHER

NCT03035812 - Alkalinization by Urologists & Nephrologists | Biotech Hunter | Biotech Hunter